Patents by Inventor Kevin Pang

Kevin Pang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12062186
    Abstract: A method, machine readable medium and system for RGBD semantic segmentation of video data includes determining semantic segmentation data and depth segmentation data for less than all classes for images of each frame of a first video, determining semantic segmentation data and depth segmentation data for images of each key frame of a second video including a synchronous combination of respective frames of the RGB video and the depth-aware video in parallel to the determination of the semantic segmentation data and the depth segmentation data for each frame of the first video, temporally and geometrically aligning respective frames of the first video and the second video, and predicting semantic segmentation data and depth segmentation data for images of a subsequent frame of the first video based on the determination of the semantic segmentation data and depth segmentation data for images of a key frame of the second video.
    Type: Grant
    Filed: October 7, 2021
    Date of Patent: August 13, 2024
    Assignee: SRI International
    Inventors: Han-Pang Chiu, Junjiao Tian, Zachary Seymour, Niluthpol C. Mithun, Alex Krasner, Mikhail Sizintsev, Abhinav Rajvanshi, Kevin Kaighn, Philip Miller, Ryan Villamil, Supun Samarasekera
  • Patent number: 7807641
    Abstract: The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.
    Type: Grant
    Filed: February 6, 2007
    Date of Patent: October 5, 2010
    Assignee: Curis, Inc.
    Inventors: Kevin Pang, Kuanghui Lu
  • Patent number: 7745216
    Abstract: The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.
    Type: Grant
    Filed: May 27, 2004
    Date of Patent: June 29, 2010
    Assignee: Curis, Inc.
    Inventors: Kevin Pang, Kuanghui Lu
  • Publication number: 20080188406
    Abstract: The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.
    Type: Application
    Filed: February 6, 2007
    Publication date: August 7, 2008
    Applicant: Curis, Inc.
    Inventors: Kevin Pang, Kuanghui Lu
  • Patent number: 7396809
    Abstract: The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: July 8, 2008
    Assignee: Curis, Inc.
    Inventors: Kuanghui Lu, Kevin Pang
  • Publication number: 20070048286
    Abstract: It is shown here that hedgehog proteins possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14.5 (E14.5) rat ventral mesencephalon, we show that hedgehog is also trophic for dopaminergic neurons. Interestingly, hedgehog not only promotes dopaminergic neuron survival, but also promotes the survival of midbrain GABA-immunoreactive (GABA-ir) neurons.
    Type: Application
    Filed: October 25, 2006
    Publication date: March 1, 2007
    Inventors: Ningning Miao, Monica Wang, Nagesh Mahanthappa, Ping Jin, Kevin Pang
  • Patent number: 7144997
    Abstract: It is shown here that hedgehog proteins possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14.5 (E14.5) rat ventral mesencephalon, we show that hedgehog is also trophic for dopaminergic neurons. Interestingly, hedgehog not only promotes dopaminergic neuron survival, but also promotes the survival of midbrain GABA-immunoreactive (GABA-ir) neurons.
    Type: Grant
    Filed: July 24, 1997
    Date of Patent: December 5, 2006
    Assignee: Curis, Inc.
    Inventors: Ningning Miao, Monica Wang, Nagesh K. Mahanthappa, Kevin Pang
  • Patent number: 7138492
    Abstract: It is shown here that hedgehog proteins possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14.5 (E14.5) rat ventral mesencephalon, we show that hedgehog is also trophic for dopaminergic neurons. Interestingly, hedgehog not only promotes dopaminergic neuron survival, but also promotes the survival of midbrain GABA-immunoreactive (GABA-ir) neurons.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: November 21, 2006
    Assignee: Curis, Inc.
    Inventors: Ningning Miao, Monica Wang, Nagesh K. Mahanthappa, Ping Jin, Kevin Pang
  • Publication number: 20060007189
    Abstract: A forms-based computer interface and method captures and interprets handwriting, pen movements, and other manual graphical-type user input for use in computerized applications and databases. An embodiment employs a portable Input and Control Device, a writing implement, and a host computing device that together capture, interpret, utilize, and store the handwriting, marks, and other pen movements of a user on and around predefined and identified forms. The Input and Control Device comprises a device for holding the predefined and identified forms and an e-clipboard for docking the holding device, capturing user input, and transmitting it to the host computing device for processing. Form, field, and user-specific handwriting and mark recognition are used in the interpretation of user input. An edit utility permits review and editing of the captured and interpreted input, permitting correction of capture and interpretation errors.
    Type: Application
    Filed: July 12, 2005
    Publication date: January 12, 2006
    Inventors: George Gaines, Kevin Pang, David Kent
  • Publication number: 20050266555
    Abstract: The present invention relates to a substantially pure population of viable pancreatic progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.
    Type: Application
    Filed: June 30, 2005
    Publication date: December 1, 2005
    Inventors: Kuanghui Lu, Kevin Pang, Lee Rubin
  • Publication number: 20050208653
    Abstract: The present invention relates to a substantially pure population of viable bile duct progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.
    Type: Application
    Filed: May 10, 2005
    Publication date: September 22, 2005
    Applicant: ES Cell International Pte Ltd.
    Inventors: Kevin Pang, Monica Homa
  • Patent number: 6946293
    Abstract: The present invention relates to a substantially pure population of viable pancreatic progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.
    Type: Grant
    Filed: August 9, 2000
    Date of Patent: September 20, 2005
    Inventors: Kuanghui Lu, Kevin Pang, Lee Rubin
  • Publication number: 20040228846
    Abstract: The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.
    Type: Application
    Filed: May 27, 2004
    Publication date: November 18, 2004
    Applicant: Curis, Inc.
    Inventors: Kevin Pang, Kuanghui Lu
  • Patent number: 6610535
    Abstract: The present invention relates to a substantially pure population of viable pancreatic progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: August 26, 2003
    Assignee: ES Cell International Pte Ltd.
    Inventors: Kuanghui Lu, Kevin Pang, Lee Rubin
  • Publication number: 20030119729
    Abstract: It is shown here that hedgehog proteins possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14.5 (E14.5) rat ventral mesencephalon, we show that hedgehog is also trophic for dopaminergic neurons. Interestingly, hedgehog not only promotes dopaminergic neuron survival, but also promotes the survival of midbrain GABA-immunoreactive (GABA-ir) neurons.
    Type: Application
    Filed: December 1, 1999
    Publication date: June 26, 2003
    Inventors: NINGNING MIAO, MONICA WANG, NAGESH K. MAHANTHAPPA, PING JIN, KEVIN PANG
  • Publication number: 20020045206
    Abstract: It is shown here that hedgehog proteins possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14.5 (E14.5) rat ventral mesencephalon, we show that hedgehog is also trophic for dopaminergic neurons. Interestingly, hedgehog not only promotes dopaminergic neuron survival, but also promotes the survival of midbrain GABA-immunoeractive (GABA-ir) neurons.
    Type: Application
    Filed: July 24, 1997
    Publication date: April 18, 2002
    Inventors: NINGNING MIAO, MONICA WANG, NAGESH K. MAHANTHAPPA, KEVIN PANG
  • Publication number: 20020012653
    Abstract: The present invention relates to a substantially pure population of viable bile duct progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.
    Type: Application
    Filed: December 19, 1997
    Publication date: January 31, 2002
    Inventors: KEVIN PANG, MONICA HOMA
  • Patent number: 6326201
    Abstract: The present invention relates to a substantially pure population of viable pancreatic progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: December 4, 2001
    Assignee: Curis, Inc.
    Inventors: Brenda Fung, Kevin Pang, David Kagan